Abstract
1. The effect of twice-daily dosing with propranolol on the pharmacokinetics and pharmacodynamics of a single oral dose of sumatriptan was investigated in 10 healthy male subjects. 2. Each subject received 7 days dosing with propranolol (80 mg twice daily) plus a single dose of sumatriptan (300 mg orally) on day 7; on another separate occasion, placebo was administered for 7 days plus a single dose of sumatriptan on day 7. There was at least a 7 day washout interval between the two periods of dosing. Pulse and blood pressure were measured up to 10 h after dosing with sumatriptan and blood samples were taken up to 26 h post-dose. 3. Propranolol had no significant effect on any of the derived pharmacokinetic parameters of sumatriptan. The appropriate average parameter values in the presence of propranolol were, respectively: Cmax (120 ng ml-1 vs 126 ng ml-1), tmax (4.5 h vs 3.0 h), AUC (580 ng ml-1 h vs 566 ng ml-1 h), t 1/2,z (1.9 h vs 1.8 h). 4. Propranolol had no significant effect on the pharmacodynamics of sumatriptan, as measured by pulse rate and blood pressure. 5. The results of this study would suggest that no alteration in the sumatriptan dosage will be necessary for migraine patients taking propranolol prophylactic therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bax N. D., Lennard M. S., Tucker G. T. Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists. Br J Clin Pharmacol. 1981 Dec;12(6):779–784. doi: 10.1111/j.1365-2125.1981.tb01306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koch G. G. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics. 1972 Jun;28(2):577–584. [PubMed] [Google Scholar]
- Lagerström P. O., Persson B. A. Liquid chromatography in the monitoring of plasma levels of antiarrhythmic drugs. J Chromatogr. 1978 Feb 11;149:331–340. doi: 10.1016/s0021-9673(00)80996-6. [DOI] [PubMed] [Google Scholar]
- Pabst G., Jaeger H. Review of methods and criteria for the evaluation of bioequivalence studies. Eur J Clin Pharmacol. 1990;38(1):5–10. doi: 10.1007/BF00314794. [DOI] [PubMed] [Google Scholar]
- Scott A. K., Park B. K., Breckenridge A. M. Interaction between warfarin and propranolol. Br J Clin Pharmacol. 1984 May;17(5):559–564. doi: 10.1111/j.1365-2125.1984.tb02390.x. [DOI] [PMC free article] [PubMed] [Google Scholar]